Drugs

GLP-1 Receptor Agonists in Heart Failure: Effects Vary by Patient Type Based on Two Analysis Methods

Updated

Abstract

An integrated systematic review and meta-analysis evaluated the effects of GLP-1 receptor agonists on heart failure.

  • GLP-1 receptor agonists are associated with reduced cardiovascular risk in patients with type 2 diabetes mellitus.
  • Evidence regarding their impact on heart failure has been growing but remains fragmented.
  • The analysis examined various trial populations and heart failure phenotypes.
  • Complementary trial-level and phenotype-based approaches were used to assess the effects.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free